Variant report

Variant	rs73047193
Chromosome Location	chr7:5594599-5594600
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	YY1	chr7:5594506-5595345	HepG2	liver:	n/a	chr7:5594729-5594743 chr7:5594945-5594954 chr7:5594735-5594749 chr7:5595002-5595013 chr7:5595010-5595021
2	POLR2A	chr7:5594447-5594825	GM12891	blood:	n/a	n/a
3	MAX	chr7:5594492-5596702	NB4	blood:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222 chr7:5596285-5596295
4	E2F4	chr7:5594506-5595841	K562	blood:	n/a	chr7:5595715-5595727 chr7:5594943-5594953 chr7:5595562-5595572
5	POLR2A	chr7:5594528-5596771	GM18505	blood:	n/a	n/a
6	BHLHE40	chr7:5594531-5595782	HepG2	liver:	n/a	chr7:5594727-5594743
7	EP300	chr7:5594596-5595052	SK-N-SH_RA	brain:	n/a	chr7:5594988-5595004 chr7:5594653-5594662 chr7:5594989-5595005
8	MAZ	chr7:5593980-5596833	IMR90	lung:	n/a	chr7:5594947-5594957 chr7:5596798-5596808 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5596285-5596295
9	GATA1	chr7:5594057-5596635	K562	blood:	n/a	chr7:5595745-5595752 chr7:5594774-5594783 chr7:5595740-5595749
10	POLR2A	chr7:5594480-5594824	SK-N-SH	brain:	n/a	n/a
11	ARID3A	chr7:5594547-5594817	K562	blood:	n/a	n/a
12	USF1	chr7:5594587-5594794	A549	lung:	n/a	chr7:5594727-5594743
13	MXI1	chr7:5593993-5596851	SK-N-SH	brain:	n/a	n/a
14	CCNT2	chr7:5594459-5596546	K562	blood:	n/a	chr7:5595560-5595569 chr7:5595815-5595824 chr7:5595723-5595732 chr7:5596363-5596372 chr7:5594686-5594706 chr7:5596261-5596270
15	MYC	chr7:5594492-5596688	K562	blood:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222 chr7:5596285-5596295
16	POLR2A	chr7:5594491-5594782	H1-hESC	embryonic stem cell:	n/a	n/a
17	ATF3	chr7:5594489-5594867	K562	blood:	n/a	chr7:5594706-5594726
18	POLR2A	chr7:5594510-5596744	HCT-116	colon:	n/a	n/a
19	POLR2A	chr7:5594497-5596721	K562	blood:	n/a	n/a
20	POU2F2	chr7:5594462-5594811	GM12878	blood:	n/a	n/a
21	TBP	chr7:5594540-5594705	H1-hESC	embryonic stem cell:	n/a	n/a
22	USF2	chr7:5594567-5594833	K562	blood:	n/a	chr7:5594727-5594743
23	POLR2A	chr7:5594585-5594802	Hela-S3	cervix:	n/a	n/a
24	CREB1	chr7:5594473-5595284	A549	lung:	n/a	n/a
25	HCFC1	chr7:5594428-5596483	K562	blood:	n/a	n/a
26	TBL1XR1	chr7:5594434-5595840	K562	blood:	n/a	n/a
27	CEBPD	chr7:5594087-5596292	K562	blood:	n/a	n/a
28	EGR1	chr7:5594394-5595174	K562	blood:	n/a	chr7:5594943-5594956 chr7:5594948-5594958 chr7:5594962-5594976 chr7:5594938-5594960 chr7:5594646-5594668 chr7:5594943-5594953 chr7:5594943-5594956 chr7:5594944-5594953 chr7:5594940-5594954 chr7:5594918-5594933 chr7:5594943-5594956 chr7:5594920-5594934 chr7:5594943-5594956 chr7:5594573-5594586
29	STAT5A	chr7:5594339-5596998	GM12878	blood:	n/a	chr7:5596281-5596293 chr7:5596276-5596288 chr7:5596257-5596269 chr7:5596111-5596118
30	CBX3	chr7:5593922-5594929	K562	blood:	n/a	n/a
31	MAX	chr7:5593983-5596790	A549	lung:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222 chr7:5596285-5596295
32	MAX	chr7:5594485-5595535	GM12878	blood:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222
33	GABPA	chr7:5594469-5594922	K562	blood:	n/a	n/a
34	NFATC1	chr7:5594335-5594806	GM12878	blood:	n/a	n/a
35	EP300	chr7:5594556-5596654	SK-N-SH	brain:	n/a	chr7:5596094-5596110 chr7:5594988-5595004 chr7:5595866-5595882 chr7:5594653-5594662 chr7:5594989-5595005
36	MAX	chr7:5594582-5596261	A549	lung:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222
37	POLR2A	chr7:5594093-5596833	Hela-S3	cervix:	n/a	n/a
38	ETS1	chr7:5594509-5594887	K562	blood:	n/a	n/a
39	POLR2A	chr7:5594228-5596651	Hela-S3	cervix:	n/a	n/a
40	USF1	chr7:5594584-5594785	HepG2	liver:	n/a	chr7:5594727-5594743
41	ZNF143	chr7:5594091-5594806	K562	blood:	n/a	n/a
42	MYC	chr7:5594492-5596557	Hela-S3	cervix:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222 chr7:5596285-5596295
43	POLR2A	chr7:5594288-5594853	HepG2	liver:	n/a	n/a
44	MAX	chr7:5594496-5596532	SK-N-SH	brain:	n/a	chr7:5595268-5595284 chr7:5595011-5595021 chr7:5594716-5594727 chr7:5596285-5596295 chr7:5595024-5595033 chr7:5596275-5596285 chr7:5595212-5595222 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5594947-5594957
45	SIN3AK20	chr7:5594455-5595274	PANC-1	pancreas:	n/a	n/a
46	MYC	chr7:5594513-5595811	K562	blood:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222
47	USF1	chr7:5594569-5594781	A549	lung:	n/a	chr7:5594727-5594743
48	MAX	chr7:5594092-5596705	K562	blood:	n/a	chr7:5594947-5594957 chr7:5595268-5595284 chr7:5594716-5594727 chr7:5596275-5596285 chr7:5595566-5595576 chr7:5594719-5594728 chr7:5595011-5595021 chr7:5595024-5595033 chr7:5595212-5595222 chr7:5596285-5596295
49	EP300	chr7:5594500-5594918	K562	blood:	n/a	chr7:5594653-5594662
50	USF1	chr7:5594503-5594822	A549	lung:	n/a	chr7:5594727-5594743

No.	Distal block	Cell Line	Cell type
1	chr16:89882793..89883690-chr7:5594533..5595391,2	Hela-S3	cervix:
2	chr7:5593112..5594944-chr7:5719558..5721902,2	MCF-7	breast:
3	chr7:5456513..5458866-chr7:5593273..5595987,2	MCF-7	breast:
4	chr7:5581518..5584209-chr7:5593146..5596180,3	MCF-7	breast:
5	chr11:62608625..62609155-chr7:5594288..5595164,2	NB4	blood:
6	chr7:5558806..5574463-chr7:5583405..5604290,160	MCF-7	breast:
7	chr7:5532197..5537592-chr7:5593884..5603950,17	MCF-7	breast:
8	chr7:5579007..5580984-chr7:5593985..5595779,2	MCF-7	breast:
9	chr7:5464910..5469932-chr7:5594160..5600416,10	MCF-7	breast:
10	chr6:74229955..74230681-chr7:5594286..5595068,2	Hela-S3	cervix:
11	chr7:5551753..5555420-chr7:5594196..5597835,12	MCF-7	breast:
12	chr7:5320876..5323087-chr7:5592627..5594710,2	K562	blood:
13	chr7:5538597..5541338-chr7:5594039..5595766,2	K562	blood:
14	chr7:5458987..5464555-chr7:5593156..5597256,5	K562	blood:
15	chr1:3447491..3448184-chr7:5594568..5595311,2	Hela-S3	cervix:
16	chr7:5566111..5566653-chr7:5594503..5595319,2	NB4	blood:
17	chr7:5462448..5464237-chr7:5593422..5596155,2	MCF-7	breast:
18	chr7:5531499..5540573-chr7:5594200..5602257,20	MCF-7	breast:
19	chr7:5464575..5468127-chr7:5593379..5596799,6	K562	blood:
20	chr7:2561342..2564063-chr7:5594340..5595887,2	MCF-7	breast:
21	chr7:5463649..5470093-chr7:5593803..5597245,7	MCF-7	breast:

Variant related genes	Relation type
ENSG00000272719	TF binding region
ENSG00000187741	Chromatin interaction
ENSG00000273084	Chromatin interaction
ENSG00000207973	Chromatin interaction
ENSG00000162591	Chromatin interaction
ENSG00000263900	Chromatin interaction
ENSG00000188365	Chromatin interaction
ENSG00000241269	Chromatin interaction
ENSG00000164638	Chromatin interaction
ENSG00000106003	Chromatin interaction
ENSG00000272953	Chromatin interaction
ENSG00000075624	Chromatin interaction
ENSG00000182095	Chromatin interaction
ENSG00000237738	Chromatin interaction
ENSG00000234432	Chromatin interaction
ENSG00000155034	Chromatin interaction

Extended variants
information (count: 34 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:14)

rs_ID	r²[population]
rs2080065	1.00[ASN][1000 genomes]
rs2080066	1.00[ASN][1000 genomes]
rs2098225	1.00[ASN][1000 genomes]
rs4724709	0.85[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs56114241	1.00[ASN][1000 genomes]
rs73047183	1.00[ASN][1000 genomes]
rs73049003	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs73049007	0.89[AMR][1000 genomes];0.92[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs73049011	0.86[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs73049012	0.83[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs73049016	0.88[EUR][1000 genomes]
rs73049019	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs73052777	0.88[EUR][1000 genomes]
rs852540	0.81[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:20 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv869165	chr7:4889618-5799719	Weak transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	352 gene(s)	inside rSNPs	diseases
2	nsv530979	chr7:5101631-5864814	Active TSS Enhancers ZNF genes & repeats Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	350 gene(s)	inside rSNPs	diseases
3	nsv530981	chr7:5157150-5920006	Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	348 gene(s)	inside rSNPs	diseases
4	esv1814049	chr7:5314993-5675131	Active TSS Strong transcription Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	333 gene(s)	inside rSNPs	diseases
5	esv1820266	chr7:5332088-5665173	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	332 gene(s)	inside rSNPs	diseases
6	nsv530983	chr7:5370746-6070852	Active TSS Strong transcription Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	368 gene(s)	inside rSNPs	diseases
7	nsv887404	chr7:5402606-5667645	Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	331 gene(s)	inside rSNPs	diseases
8	nsv916391	chr7:5417945-5889565	Flanking Active TSS Enhancers ZNF genes & repeats Weak transcription Genic enhancers Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	336 gene(s)	inside rSNPs	diseases
9	nsv887407	chr7:5432672-5605130	Enhancers Flanking Active TSS Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA	302 gene(s)	inside rSNPs	diseases
10	nsv887408	chr7:5432672-5667645	Enhancers Active TSS Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	331 gene(s)	inside rSNPs	diseases
11	nsv830890	chr7:5464933-5705158	Flanking Active TSS Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	322 gene(s)	inside rSNPs	diseases
12	nsv533108	chr7:5488018-6316581	Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers Genic enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	390 gene(s)	inside rSNPs	diseases
13	nsv887413	chr7:5521468-5607884	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA	279 gene(s)	inside rSNPs	diseases
14	nsv1025434	chr7:5537571-5705283	Genic enhancers Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	297 gene(s)	inside rSNPs	diseases
15	nsv482449	chr7:5557585-5743673	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	294 gene(s)	inside rSNPs	diseases
16	nsv1033556	chr7:5565080-6186815	Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	357 gene(s)	inside rSNPs	diseases
17	nsv538710	chr7:5565080-6186815	Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	357 gene(s)	inside rSNPs	diseases
18	nsv887414	chr7:5584934-5667645	Flanking Bivalent TSS/Enh Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	67 gene(s)	inside rSNPs	diseases
19	nsv887415	chr7:5584934-5675305	Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	67 gene(s)	inside rSNPs	diseases
20	nsv887416	chr7:5584934-5695259	Genic enhancers Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	68 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:108 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:5572600-5594600	Weak transcription	Right Atrium	heart
2	chr7:5588800-5595000	Enhancers	Placenta	Placenta
3	chr7:5589400-5595000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr7:5589400-5595200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
5	chr7:5589600-5594600	Weak transcription	Primary T helper cells fromperipheralblood	blood
6	chr7:5589600-5594800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
7	chr7:5589600-5595000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
8	chr7:5589600-5595000	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
9	chr7:5589600-5595200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
10	chr7:5591600-5595000	Enhancers	Fetal Intestine Large	intestine
11	chr7:5591800-5595000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr7:5592400-5594600	Flanking Active TSS	Hela-S3	cervix
13	chr7:5592400-5595000	Enhancers	Liver	Liver
14	chr7:5592600-5594800	Enhancers	Rectal Mucosa Donor 31	rectum
15	chr7:5592600-5595000	Enhancers	Stomach Mucosa	stomach
16	chr7:5592800-5594600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr7:5593000-5595000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr7:5593000-5595000	Enhancers	Rectal Mucosa Donor 29	rectum
19	chr7:5593000-5595000	Enhancers	NHEK	skin
20	chr7:5593200-5595200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr7:5593400-5595000	Weak transcription	HSMM	muscle
22	chr7:5593400-5595200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr7:5593600-5595000	Weak transcription	HSMMtube	muscle
24	chr7:5593800-5594600	Weak transcription	Sigmoid Colon	Sigmoid Colon
25	chr7:5594000-5594600	Flanking Active TSS	Rectal Smooth Muscle	rectum
26	chr7:5594000-5595000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr7:5594000-5595000	Enhancers	Primary T cells fromperipheralblood	blood
28	chr7:5594000-5595000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr7:5594000-5595000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
30	chr7:5594200-5594600	Enhancers	H1 Cell Line	embryonic stem cell
31	chr7:5594200-5594600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
32	chr7:5594200-5594600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr7:5594200-5594600	Enhancers	Adipose Nuclei	Adipose
34	chr7:5594200-5594600	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
35	chr7:5594200-5594600	Enhancers	Skeletal Muscle Male	skeletal muscle
36	chr7:5594200-5594600	Flanking Active TSS	A549	lung
37	chr7:5594200-5594600	Flanking Active TSS	GM12878-XiMat	blood
38	chr7:5594200-5594600	Flanking Active TSS	K562	blood
39	chr7:5594200-5594800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
40	chr7:5594200-5594800	Enhancers	Primary B cells from peripheral blood	blood
41	chr7:5594200-5594800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
42	chr7:5594200-5595000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr7:5594200-5595000	Enhancers	Primary hematopoietic stem cells	blood
44	chr7:5594200-5595000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr7:5594200-5595000	Enhancers	Brain Substantia Nigra	brain
46	chr7:5594200-5595000	Enhancers	Duodenum Mucosa	Duodenum
47	chr7:5594200-5595000	Enhancers	Left Ventricle	heart
48	chr7:5594200-5595000	Enhancers	Lung	lung
49	chr7:5594200-5595000	Enhancers	Placenta Amnion	Placenta Amnion
50	chr7:5594200-5595000	Bivalent/Poised TSS	Thymus	Thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links